Home | Back to newsletter main page
| |
 |
|
November 26, 2012 |
|
CASE CCC IN THE NEWSUnraveling the Breast Cancer Genome Gives Hope for a Cure Genetic Factor Holds Key to Blood Vessel Health ANNOUNCEMENTSDr. Harter Receives Funding for Melanoma Research
FUNDING OPPORTUNITIES/AWARDSOncology Nursing Certification Corporation: Advanced Oncology Certified Nurse of the Year AwardThe Advanced Oncology Certified Nurse of the Year Award recognizes an AOCN/AOCNP/AOCNS who has made significant contributions to oncology nursing and oncology nursing service, and who has supported and promoted oncology nursing certification. The Advanced Oncology Certified Nurse of the Year will receive $1,000 and be presented with a crystal award at the Recognition Breakfast for Oncology Certified Nurses at the ONS Annual Congress. Deadline: December 15 Beez FoundationThe Beez Foundation for Pediatric Brain Cancer works to cure brain cancer through research, public awareness, and related support activities for pediatric cancer treatment. The primary goal of the foundation is to identify and target key areas in the field of children's brain cancer research and patient services that are presently underfunded. The Foundation is soliciting proposals in three areas: Pediatric Brain Cancer Research, Education or Patient Services. Deadline: January 2, 2013 Society of Surgical Oncology Clinical Investigator AwardsThe James Ewing Foundation of the Society of Surgical Oncology is accepting applications for its 2013 cycle of Clinical Investigator Awards. The purpose of these awards is to promote patient-oriented research conducted by surgical oncologists in clinical and translational science. Applicants must be surgical oncologists within 10 years of completion of training and be full SSO members. Deadline: January 7, 2013 Oncology Nursing Society Foundation ScholarshipsThe Oncology Nursing Society Foundation is offering scholarships to registered nurses who are interested in and committed to oncology nursing to continue their education by pursuing a master's degree in nursing, research doctoral degree (PhD or DNSc), or clinical doctoral degree (DNP). Deadline: February 1, 2013 MARK YOUR CALENDARSWebinar: Ensuring Equal Access to Cancer Research: How Does Bias Play a Role in Who is Offered Clinical Trial Participation?Registration is open for Ensuring Equal Access to Cancer Research: How Does Bias Play a Role in Who is Offered Clinical Trial Participation?, a webinar to be held on Tuesday, December 11 from 1-2:30 pm in BRB 105. Presented by the Education Network in Advance Cancer Clinical Trials (ENACCT), speakers include Terrance Albrecht, PhD and Carma Bylund, PhD. Studies have found that very few cancer patients are informed about the option of participating in a cancer clinical trial. Even at major cancer centers, oncologists may not approach all eligible patients about participation and patients from minority groups or who are 65 or older may be less likely to be approached, regardless of eligibility. It has been suggested that providers' implicit bias, rather than overt prejudice, can influence provider clinical decision making and quality of care delivered, contributing to treatment disparities. This webinar will review the literature on these biases and explore strategies for managing bias to maximize opportunities for equal patient access to cancer clinical trials. Objectives of this webinar include:
So You Want To Do Comparative Effectiveness Research? The Nuts and Bolts of CERRegistration is open for So You Want To Do Comparative Effectiveness Research? The Nuts and Bolts of CER, to be held Friday, December 14 in the WRB Auditorium. This half-day symposium will help heighten the understanding of comparative effectiveness research (CER), identify strategies to evaluate competing treatments and highlight the various research design methods available to perform CER. The course will be taught at an introductory level and is designed to provide resources for investigators to pursue future research projects. There is $25 registration fee, though this fee is waived for trainees, scholars, and K awardees. CER is defined as the direct comparison of existing health care interventions to determine which work best for which patients and which pose the greatest benefits and harms. CER is receiving increasing importance nationally and internationally as a priority area of investigation and has led to the establishment of the Patient-Centered Outcomes Research Institute (PCORI). | EVENTS
November 26Cancer Center Chalk Talk Pathology Research Seminar Series Skeletal Research Center Seminar Series November 27Cancer Biology Fellow Seminar Immunology Seminar Series Medicine Grand Rounds November 28Hematology and Oncology Research Conference Immunology Faculty Research in Progress Seminar November 29Miltenyi Biotec Seminar and Machine Demonstration November 30Hematology/Oncology Fellows Conference/Curriculum Series Taussig Cancer Institute Grand Rounds Cancer Center Seminar Series Cancer Center Research in Progress
UPCOMING CANCER CENTER SYMPOSIUMS & EVENTS16th Annual Meeting of the Translational Research Cancer Centers Consortium (TRC3): The Power of Negative Thinking: Inhibiting the Inhibitors of Tumor Immunity
ADDITIONAL UPCOMING SEMINARS & EVENTSThe Cancer Genome Atlas 2nd Annual Scientific Symposium: Enabling Cancer Research Through TCGA American Society of Hematology (ASH) Annual Meeting So You Want To Do Comparative Effectiveness Research? The Nuts and Bolts of CER Pacific Symposium on Biocomputing 2013 |
|
|
|
PREVIOUSLY ANNOUNCED OPPORTUNITIES |
|
|
Limited Submission: NIH Director's Early Independence Award |
Alex's Lemonade Stand Foundation Young Investigator Awards |
|
|
|
NIH BULLETIN – Notices and Funding OpportunitiesMitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R01)(PA-11-073) Mitochondria in Cancer Epidemiology, Detection, Diagnosis and Prognosis (R21)(PA-11-074) |
|
| Produced by: Gillian Irwin Todd 11100 Euclid Avenue, Wearn 149 Cleveland, Ohio 44106-5065 216.844.8317 phone 216.844.7832 fax gillian.irwin@case.edu |
HELP US HELP YOU!If you have a new grant, recently won an award, or have other newsworthy items, please let us know so we can publicize them in the newsletter and other media outlets. You deserve the accolades! Send items to gillian.irwin@case.edu. |
|
|
M.L. (Nikki) Harter, PhD, has received an R21 grant from NIH. This grant is designed to further her promising discoveries on the effect of solar UVR in the development of melanoma. Dr. Harter will receive $241,500 for two years.